http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112015000497-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40
filingDate 2013-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_735cb181e557e3f0ab3d178dd6b6d794
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e2f6d3c71983c1bca2da4a107c210b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af5de97f9862cd837efee218c98735f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87c2c17e81e192e17058308f5edccb0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ceaab5c078f05a8c08e6d1958d22096d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b804cae4759a499212388ea4f258e483
publicationDate 2017-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112015000497-A2
titleOfInvention anti-tumor composition comprising 1- (6 - {[6- (4-fluorophenyl) [1,2,4] triazolo [4,3-b] pyridazin-3-yl] sulfanyl} -1,3-benzothiazole -2-yl) -3- (2-morpholin-4-ylethyl) urea
abstract abstract the present invention concerns an anti-tumor composition comprising the compound 1- (6 - {[6- (4-fluorophenyl) [1,2,4] triazolo [4,3-b] pyridazin-3-yl] sulfanyl} -1,3-benzothiazol-2-yl) -3- (2-morpholin-4-ylethyl) urea and its use in the treatment of cancer. "anti-tumor composition comprising the compound 1- (6 - {[6- (4-fluorophenyl) [1,2,4] triazolo [4,3-b] pyridazin-3-yl"). ] sulfanyl} -1,3-benzothiazol-2-yl) -3- (2-morpholin-4-ylethyl) urea ". The present invention relates to an antitumor composition comprising 1- (6 - {[6- (4-fluorophenyl) [1,2,4] triazolo [4,3-b] pyridazin-3-yl] sulfanyl} -1,3-benzothiazol-2-yl) -3- (2-morpholin-4-ylethyl) urea, and their use in cancer treatment.
priorityDate 2012-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420084229
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397808
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25182860

Total number of triples: 28.